Nifty Pharma Today: Index Rises 0.84% to 26,848.75

Quick sector takeaways

• Nifty Pharma ended 0.84% higher, adding 222.45 points to close at 26,848.75.
• The index finished above its previous close of 26,626.30 and just 7.30 points below its day high of 26,856.05.
• Breadth was positive: 13 of 20 tracked stocks advanced, while seven declined. Zydus Lifesciences, Laurus Labs and Torrent Pharmaceuticals were among the leading gainers.
• For the next session, investors can track whether the index holds near its closing level and how the mixed moves in stocks such as JB Chemicals, Lupin and Gland Pharma develop.

In the 27 August 2026 closing bell update, nifty pharma today stood out as the top gaining sector index among the configured sector indices. The index ended the session at 26,848.75, up 222.45 points, or 0.84%, from 26,626.30. Data in this update was recorded at 4:15:00 PM IST.

Nifty Pharma today: an end-of-session strength check

Nifty Pharma opened at 26,677.15, already above the previous close, and traded between 26,607.95 and 26,856.05 through the day. Its closing level of 26,848.75 placed it near the session high, reflecting a firm end to the day in index terms. The gain was accompanied by positive participation across the sector, although stock-level performance was not uniform.

The 0.84% advance was the strongest gain among the configured sector indices for the session. This makes the pharma index the key positive sectoral reference point in the closing bell picture, based on the reported index moves. The closing value was also 171.60 points above the day’s opening level, showing that the index improved from its opening mark by the end of trade.

Price snapshot

The intraday range was 248.10 points from low to high. Importantly, the final level sat close to the top of that range rather than near the low. That is an observation on the day’s price positioning, not an indication of what the index will do next.

Sector ranking

Nifty Pharma ranked first among the configured sector indices by percentage gain on 27 August. Its 0.84% rise was ahead of Nifty Mid Select, which was marginally higher by 0.01%, while several other tracked sector indices ended lower. As a result, pharma was the session’s top gaining sector index in this comparison.

This ranking gives the move added context: the index’s advance was not simply positive in isolation; it was the strongest reported gain across the configured group. Readers following the broader market can review the wider closing-bell dashboard through Univest Market View.

Constituent breadth

Participation within the index was constructive. Of the 20 display-safe stocks tracked, 13 advanced and seven declined, with no unchanged stocks. The advance-decline ratio was 1.86, meaning gainers outnumbered decliners by a meaningful margin.

Positive breadth matters because the index rise was accompanied by gains across more stocks than losses. At the same time, the presence of seven decliners shows that the session was selective rather than uniformly positive. The spread between leaders and laggards remained wide, with Zydus Lifesciences rising 3.41% and JB Chemicals & Pharmaceuticals falling 3.87%.

Heavyweights versus broader participation

The supplied heavyweight set presented a broadly positive picture. Sun Pharmaceutical Industries rose 0.73% to 1,913.30, while Divi’s Laboratories gained 0.39% to 9,060. Torrent Pharmaceuticals added 2.23% to 4,999 and Cipla advanced 1.23% to 1,420. Dr. Reddy’s Laboratories was lower by 0.42% at 1,177.

The listed active-stock set included Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy’s Laboratories. Within this group, four stocks ended higher and one ended lower. Torrent Pharmaceuticals and Cipla closed at their respective day highs, while their closing positions are simply intraday price observations.

Key Nifty Pharma stocks

Biggest positive movers

Zydus Lifesciences led the gainers with a 3.41% rise to 1,189.20, after trading between 1,142.10 and 1,195.40. Laurus Labs followed with a 2.25% increase to 1,929.40, closing close to its day high of 1,930. Torrent Pharmaceuticals gained 2.23% to 4,999, its reported day high. Cipla added 1.23% to 1,420, also at its day high, while Mankind Pharma rose 0.99% to 2,417.50.

Biggest negative movers

JB Chemicals & Pharmaceuticals declined 3.87% to 2,408.90, after a day range of 2,380 to 2,525.50. Lupin fell 1.23% to 2,158.10 and Gland Pharma slipped 1.02% to 2,873.50. Abbott India was down 0.77% at 26,350, while Natco Pharma declined 0.67% to 857.60. These declines coexisted with the index’s positive overall finish.

Stocks to watch next session

• Zydus Lifesciences, following its sector-leading 3.41% advance.
• Laurus Labs, which closed at 1,929.40, close to its day high.
• Torrent Pharmaceuticals, which ended at its day high of 4,999.
• Cipla, which also finished at its day high of 1,420.
• JB Chemicals & Pharmaceuticals, the session’s largest percentage decliner.
• Lupin, after its 1.23% decline to 2,158.10.

The constructive case

The constructive evidence is clear in the reported numbers: Nifty Pharma gained 0.84%, closed near its day high, and had 13 advancing stocks against seven decliners. Leading gains in Zydus Lifesciences, Laurus Labs, Torrent Pharmaceuticals and Cipla added to the positive cross-section of stock moves. Positive moves among several supplied heavyweight names also aligned with the higher index close.

The cautious case

The session still contained notable stock-specific weakness. JB Chemicals & Pharmaceuticals fell 3.87%, while Lupin, Gland Pharma, Abbott India, Natco Pharma, Dr. Reddy’s Laboratories and Ajanta Pharma also ended lower. The index’s near-high close and positive breadth describe this session only; the next session’s direction will depend on fresh price action across both leaders and laggards.

Univest Insights

The closing-bell outcome for nifty pharma today was constructive on both index direction and breadth. A 222.45-point gain from the previous close, together with a finish just below the day high, placed pharma at the top of the configured sector ranking.

The leadership was distributed across multiple names rather than resting on a single stock. Zydus Lifesciences led the percentage gainers, while Laurus Labs, Torrent Pharmaceuticals, Cipla and Mankind Pharma also posted notable advances. This breadth complemented positive moves in supplied heavyweight stocks such as Sun Pharmaceutical Industries and Divi’s Laboratories.

However, the divergence in constituent returns remains relevant. The sharp decline in JB Chemicals & Pharmaceuticals and lower closes in several peers underline that stock selection and sector direction did not move in lockstep during the session.

For traders and investors, the key signal to watch is…

Published on 27 August 2026 at 4:15 PM IST

Frequently asked questions

What was Nifty Pharma today?

Nifty Pharma ended at 26,848.75 on 27 August 2026, up 222.45 points or 0.84% from its previous close of 26,626.30.

Why was Nifty Pharma the top gaining sector index?

Its 0.84% gain was the highest percentage advance among the configured sector indices in the supplied closing-bell data.

What were Nifty Pharma’s day high and day low?

The index recorded a day high of 26,856.05 and a day low of 26,607.95.

How was Nifty Pharma’s breadth at the close?

Thirteen of 20 tracked stocks advanced and seven declined, with no unchanged stocks.

Which stocks were the top gainers in Nifty Pharma?

Zydus Lifesciences gained 3.41%, Laurus Labs rose 2.25%, and Torrent Pharmaceuticals added 2.23%.

Which stock fell the most in Nifty Pharma?

JB Chemicals & Pharmaceuticals was the largest percentage decliner, falling 3.87% to 2,408.90.